Showing results (11-20 of 27) with videos related to

Sort By:
Pageof 3
British Journal of Haematology|December 21, 2000
Late outcomes after bone marrow transplant for aplastic anaemiaM Eapen, N K Ramsay, A C Mertens, et al.
Bone Marrow Transplantation|December 13, 2016
MDS disease characteristics, not donor source, predict hematopoietic stem cell transplant outcomesH Pourhassan, T DeFor, B Trottier, et al.
Blood|May 9, 2001
Survival after transplantation of unrelated donor umbilical cord blood is comparable to that of human leukocyte antigen-matched unrelated donor bone marrow: results of a matched-pair analysisJ N Barker, S M Davies, T DeFor, et al.
Bone Marrow Transplantation|March 7, 1998
Early gram-positive bacteremia in BMT recipients: impact of three different approaches to antimicrobial prophylaxisC Arns da Cunha, D Weisdorf, X O Shu, et al.
Blood|August 26, 1998
Comparative analysis of autografting in chronic myelogenous leukemia: effects of priming regimen and marrow or blood origin of stem cellsC M Verfaillie, R Bhatia, M Steinbuch, et al.
Bone Marrow Transplantation|November 10, 2009
Pre-transplant risk factors affecting outcome in Hurler syndromeP J Orchard, C Milla, E Braunlin, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|September 1, 2001
Low incidence of Epstein-Barr virus-associated posttransplantation lymphoproliferative disorders in 272 unrelated-donor umbilical cord blood transplant recipientsJ N Barker, P L Martin, J E Coad, et al.
Bone Marrow Transplantation|March 20, 1999
B cell lymphoproliferative disorders following hematopoietic stem cell transplantation: risk factors, treatment and outcomeT G Gross, M Steinbuch, T DeFor, et al.
Bone Marrow Transplantation|February 16, 2000
Pulmonary cytolytic thrombi: a newly recognized complication of stem cell transplantationJ P Woodard, E Gulbahce, M Shreve, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|September 7, 2000
A randomized trial comparing prednisone with antithymocyte globulin/prednisone as an initial systemic therapy for moderately severe acute graft-versus-host diseaseL Cragg, B R Blazar, T Defor, et al.
Pageof 3